Search

everythinglearnresearchcommunity

for

Search:↓

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Severe insulin resistance can be managed with medication, lifestyle changes, and treatment for related conditions.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

Continuous light exposure in rats leads to PCOS-like symptoms and suggests sleep habits might affect the disorder's development.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Recent genetic insights show that low-renin hypertension includes a range from essential hypertension to secondary or familial forms, affecting diagnosis and treatment.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Prenatal stress changes how male and female rats enjoy rewards differently, linked to sex hormones.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Suppressing certain hormones might help prevent prostate cancer.

The enzyme 5α-reductase is key in causing psychotic-like effects from sleep deprivation.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

Finasteride significantly reduces hair growth in women with idiopathic hirsutism.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

Phototrichogram and hair diameter measurements are effective, noninvasive ways to assess hair growth and detect early hair loss, with the most common pattern being reduced hair density.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

Finasteride can cause sexual problems and depression in young men.

The document concludes that veterinary dermatologists need more experience and a better approach to treating skin diseases in nonhuman primates.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

Cyclodextrins improve how steroid drugs work and are used in marketed medications and environmental applications.